Mina Hassan‐Zahraee

1.2k total citations
30 papers, 830 citations indexed

About

Mina Hassan‐Zahraee is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Mina Hassan‐Zahraee has authored 30 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Genetics and 11 papers in Epidemiology. Recurrent topics in Mina Hassan‐Zahraee's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (11 papers) and Immune Cell Function and Interaction (6 papers). Mina Hassan‐Zahraee is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (11 papers) and Immune Cell Function and Interaction (6 papers). Mina Hassan‐Zahraee collaborates with scholars based in United States, Canada and Italy. Mina Hassan‐Zahraee's co-authors include Fabio Cataldi, Kenneth E. Hung, Walter Reinisch, Silvio Danese, Maria Kłopocka, William J. Sandborn, Alaa Ahmad, Dino Tarabar, Kenneth J. Gorelick and John Yee and has published in prestigious journals such as The Lancet, The Journal of Immunology and Gastroenterology.

In The Last Decade

Mina Hassan‐Zahraee

29 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mina Hassan‐Zahraee United States 14 393 353 214 154 102 30 830
Sho Takagi Japan 20 282 0.7× 655 1.9× 433 2.0× 243 1.6× 376 3.7× 62 1.4k
Luis Acero United States 9 797 2.0× 125 0.4× 83 0.4× 205 1.3× 95 0.9× 10 1.2k
Mia J. Smith United States 18 469 1.2× 336 1.0× 67 0.3× 215 1.4× 213 2.1× 37 1.0k
Klaartje Kok United Kingdom 13 206 0.5× 226 0.6× 141 0.7× 365 2.4× 162 1.6× 33 843
Simone Pfennig Germany 18 514 1.3× 678 1.9× 386 1.8× 116 0.8× 211 2.1× 25 1.2k
A. Christopher Stevens United States 11 304 0.8× 201 0.6× 231 1.1× 111 0.7× 149 1.5× 13 789
Matthew J. Butcher United States 10 524 1.3× 93 0.3× 167 0.8× 198 1.3× 131 1.3× 14 819
Sébastien André France 17 404 1.0× 117 0.3× 289 1.4× 332 2.2× 72 0.7× 37 1.2k
M. Zaeem Cader United Kingdom 9 365 0.9× 169 0.5× 71 0.3× 296 1.9× 115 1.1× 13 883

Countries citing papers authored by Mina Hassan‐Zahraee

Since Specialization
Citations

This map shows the geographic impact of Mina Hassan‐Zahraee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mina Hassan‐Zahraee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mina Hassan‐Zahraee more than expected).

Fields of papers citing papers by Mina Hassan‐Zahraee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mina Hassan‐Zahraee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mina Hassan‐Zahraee. The network helps show where Mina Hassan‐Zahraee may publish in the future.

Co-authorship network of co-authors of Mina Hassan‐Zahraee

This figure shows the co-authorship network connecting the top 25 collaborators of Mina Hassan‐Zahraee. A scholar is included among the top collaborators of Mina Hassan‐Zahraee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mina Hassan‐Zahraee. Mina Hassan‐Zahraee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Kenneth E., S. Aggarwal, Sharron Gargosky, et al.. (2025). P1097 Phase 1/2 study to assess safety, tolerability, and efficacy of XmAb942 (anti-TL1A) in healthy participants and participants with ulcerative colitis. Journal of Crohn s and Colitis. 19(Supplement_1). i2015–i2015.
2.
Peeva, Elena, Yuji Yamaguchi, Zhan Ye, et al.. (2024). Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses. Experimental Dermatology. 33(9). e15177–e15177. 2 indexed citations
3.
4.
Guttman‐Yassky, Emma, Ester Del Duca, Joel Corrêa da Rosa, et al.. (2023). Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo. Journal of Allergy and Clinical Immunology. 153(1). 161–172.e8. 27 indexed citations
5.
Hassan‐Zahraee, Mina, Zhan Ye, Xi Li, et al.. (2023). Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis. Journal of Crohn s and Colitis. 18(9). 1361–1370. 7 indexed citations
6.
Sandborn, William J., Silvio Danese, Jarosław Leszczyszyn, et al.. (2023). Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study. Clinical Gastroenterology and Hepatology. 21(10). 2616–2628.e7. 57 indexed citations
7.
Li, Xi, Sandra Garcet, Zhan Ye, et al.. (2022). A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis. Scientific Reports. 12(1). 19740–19740. 11 indexed citations
8.
Danese, Silvio, Maria Kłopocka, Ellen Scherl, et al.. (2021). Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study. Clinical Gastroenterology and Hepatology. 19(11). 2324–2332.e6. 60 indexed citations
9.
Banfield, Christopher, Dan Rudin, Indranil Bhattacharya, et al.. (2019). First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects. British Journal of Clinical Pharmacology. 86(4). 812–824. 21 indexed citations
10.
Vermeire, Séverine, William J. Sandborn, Silvio Danese, et al.. (2017). Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. 390(10090). 135–144. 146 indexed citations
11.
D’Haens, Geert, Dino Tarabar, Édouard Louis, et al.. (2015). OP023. Methotrexate for corticosteroid-dependent ulcerative colitis: results of a placebo randomized controlled trial.. Journal of Crohn s and Colitis. 9(suppl 1). S14–S15. 1 indexed citations
12.
Karlsson, Fridrik & Mina Hassan‐Zahraee. (2015). Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation. Current Protocols in Cytometry. 71(1). 6.35.1–6.35.7. 9 indexed citations
13.
Thakker, Paresh, Suzana Marušić, Nancy Stedman, et al.. (2011). Cytosolic Phospholipase A2α Blockade Abrogates Disease during the Tissue-Damage Effector Phase of Experimental Autoimmune Encephalomyelitis by Its Action on APCs. The Journal of Immunology. 187(4). 1986–1997. 13 indexed citations
14.
SenGupta, Devi, Philip J. Norris, Todd J. Suscovich, et al.. (2004). Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II. The Journal of Immunology. 173(3). 1987–1993. 63 indexed citations
15.
Zehntner, Simone P., Lyne Bourbonnière, Mina Hassan‐Zahraee, Elise Tran, & Trevor Owens. (2004). Bone marrow-derived versus parenchymal sources of inducible nitric oxide synthase in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 150(1-2). 70–79. 14 indexed citations
16.
Hassan‐Zahraee, Mina, Uma Ladiwala, Pascal M. Lavoie, et al.. (2000). Superantigen presenting capacity of human astrocytes. Journal of Neuroimmunology. 102(2). 131–136. 5 indexed citations
17.
Hassan‐Zahraee, Mina, Elise H. Tran, Lyne Bourbonnière, & Trevor Owens. (2000). Elevated interferon-gamma in CNS inflammatory disease: a potential complication for bone marrow reconstitution in MS. Journal of Neuroimmunology. 108(1-2). 40–44. 4 indexed citations
18.
Hassan‐Zahraee, Mina. (1998). Rapid synthesis of IFN-gamma by T cells in skin may play a pivotal role in the human skin immune system. International Immunology. 10(11). 1599–1612. 10 indexed citations
19.
Owens, Trevor, et al.. (1998). Immune cell entry to the CNS — a focus for immunoregulation of EAE. Research in Immunology. 149(9). 781–789. 35 indexed citations
20.
Christou, Nicolas V., Jonathan L. Meakins, Julius Gordon, et al.. (1995). The Delayed Hypersensitivity Response and Host Resistance in Surgical Patients. Annals of Surgery. 222(4). 534–548. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sho Takagi Breakdown of academic impact, for papers by Luis Acero Breakdown of academic impact, for papers by Mia J. Smith Breakdown of academic impact, for papers by Klaartje Kok Breakdown of academic impact, for papers by Simone Pfennig Breakdown of academic impact, for papers by A. Christopher Stevens Breakdown of academic impact, for papers by Matthew J. Butcher Breakdown of academic impact, for papers by Sébastien André Breakdown of academic impact, for papers by M. Zaeem Cader
Rankless by CCL
2026